RecruitingNot ApplicableNCT05239364

Ablation of Consecutive Atrial Tachycardia

Ablation of CONseCutive atriaL Tachycardia gUided by Ultra-high-DEnsity Mapping


Sponsor

Evangelical Hospital Düsseldorf

Enrollment

100 participants

Start Date

Dec 22, 2020

Study Type

INTERVENTIONAL

Conditions

Summary

Ablation of consecutive atrial tachycardia (AT) after ablation of atrial fibrillation (AF) or cardiac surgery can be challenging due to complex substrate and AT mechanisms. A substantial portion of patients is known to show various tachycardias and recurrences occur in a noticeable number of cases. With the availability of novel ultra-high-density mapping techniques characterization and understanding of AT mechanisms and underlying substrate can be improved. Aim of this prospective, multi-center, randomized study is to compare a standard AT ablation approach versus minimalized ablation of the clinical AT in regards to arrhythmia free survival.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Consecutive AT subsequent to prior AF ablation procedure or cardiac surgery
  • Surface ECG-documentation of AT as primary clinical arrhythmia
  • ECG indicating stable, map-able AT (stable activation sequence, and CL stability) with cycle length ≥ 200ms

Exclusion Criteria7

  • < 18 years
  • No previous atrial fibrillation ablation procedure or cardiac surgery
  • Pregnant women or women of childbearing potential without a negative pregnancy test within 48 hours prior to treatment
  • History of hemorrhagic diathesis or other coagulopathies
  • Contraindications for oral anticoagulation
  • Hyper- or hypothyroidism
  • Has any condition that would make participation not be in the best interest of the subject

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURECatheter ablation

Catheter-based ablation of arrhythmias using radiofrequency.


Locations(6)

Asklepios St. Georg

Hamburg, Free and Hanseatic City of Hamburg, Germany

Evangelic Hospital Düsseldorf

Düsseldorf, North Rhine-Westfalia, Germany

Vivantes Klinikum Am Urban Berlin

Berlin, Germany

Evangelic Hospital Hagen-Haspe

Hagen, Germany

Städtisches Klinikum Karlsruhe

Karlsruhe, Germany

Universitätsklinikum Schleswig Holstein

Kiel, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05239364


Related Trials